Medtronic Infuse Bone Graft Lawyers at Bernstein Liebhard LLP Comment...
The Firm is currently investigating Medtronic Infuse Bone Graft lawsuits on behalf of individuals who suffered serious complications, including respiratory problems, cancer, nerve damage or wrongful...(PRWeb February 21, 2013)Read the full story at http://www.prweb.com/releases/medtronic-infuse-lawsuit/infuse-bone-graft/prweb10458281.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 23, 2013 Category: Pharmaceuticals Source Type: news

Brain Location For Stem Cell Transplantation Crucial For Cell Survival
Researchers at the Johns Hopkins University in Baltimore, Md., and the Mossakowski Medical Research Centre in Warsaw, Poland, have found that nonself-donated cells (allografts) better survive implantation into the brains of immunocompetent research mice when the grafts are injected into the striatum (STR) of the brain rather than injected into the forceps minor (FM) region. In their study, all FM grafts were rejected while STR grafts accumulated and survived along the border between the striatum and the corpus callosum... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 16, 2013 Category: Consumer Health News Tags: Stem Cell Research Source Type: news

Concurrent sinus lift and graft: thoughts on approach?
I have treatment planned a patient for a sinus lift via lateral window, bone graft for vertical and horizontal ridge augmentation and implant installation. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - February 15, 2013 Category: Dentistry Authors: osseonews Tags: Dental Implant Cases Source Type: news

Impact of stem cell transplantation location in brain a crucial factor for cell survival
(Cell Transplantation Center of Excellence for Aging and Brain Repair) Researchers found that nonself-donated cells better survive implantation into brains of immunocompetent research mice when grafts are injected into the striatum (STR) of the brain rather than injected into the forceps minor (FM) region. All FM grafts were rejected; STR grafts accumulated and survived along the border between the striatum and the corpus callosum. Researchers concluded that allograft survival within the CNS of an immunocompetent, non-immune suppressed host may be dependent on implantation site. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2013 Category: Global & Universal Source Type: news

Using Frozen Allograft Bone for Acetabular ReconstructionUsing Frozen Allograft Bone for Acetabular Reconstruction
There are advantages of using untreated fresh frozen non-irradiated allografts in acetabular reconstruction -- but is there a risk of alloimmunization? BMC Musculoskeletal Disorders (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 8, 2013 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

Tunneling techniques for bone grafting: is it successful?
I have seen tunneling techniques [subperiosteal tunneled flap with particulate bone graft material] for grafting between molars and premolars. This procedure looks very simple. How successful is this technique? (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - January 30, 2013 Category: Dentistry Authors: osseonews Tags: Dental Implants Q&A Source Type: news

Antibodies in Transplantation: The Effects of HLA and Non-HLA Antibody Binding and Mechanisms of Injury
Until recently, allograft rejection was thought to be mediated primarily by alloreactive T cells. Consequently, immunosuppressive approaches focused on inhibition of T cell activation. While short-term graft survival has significantly improved and rejection rates have dropped, acute rejection has not been eliminated and chronic rejection remains the major threat to long-term graft survival. Increased attention to humoral immunity in experimental systems and in the clinic has revealed that donor specific antibodies (DSA) can mediate and promote acute and chronic rejection. Herein, we detail the effects of alloantibody, part...
Source: Springer protocols feed by Immunology - January 1, 2013 Category: Allergy & Immunology Source Type: news

Thoracic Organ Transplantation: Laboratory Methods
Although great progress has been achieved in thoracic organ transplantation through the development of effective immunosuppression, there is still significant risk of rejection during the early post-transplant period, creating a need for routine monitoring for both acute antibody and cellular mediated rejection. The currently available multiplexed, microbead assays utilizing solubilized HLA antigens afford the capability of sensitive detection and identification of HLA and non-HLA specific antibodies. These assays are being used to assess the relative strength of donor specific antibodies; to permit performance of virtual ...
Source: Springer protocols feed by Immunology - January 1, 2013 Category: Allergy & Immunology Source Type: news

Lymphocyte Crossmatching by Flow Cytometry
Flow cytometry is an invaluable tool for studying lymphocyte biology. In transplantation, flow cytometry represents the most sensitive method for demonstrating the binding of HLA antibodies to cellular targets. Referred to as the flow cytometric crossmatch (FCXM), the implementation of this method has revolutionized HLA antibody assessments and facilitated increased allograft survival among highly sensitized recipients. Here we describe the methods for performing the FCXM and discuss its critical aspects, as well as the presentation of data and interpretation of results. (Source: Springer protocols feed by Immunology)
Source: Springer protocols feed by Immunology - January 1, 2013 Category: Allergy & Immunology Source Type: news

Stryker Submits OP-1 Implant For U.S., European Approval
Creative BioMolecules, Inc. announced that Stryker Corp., its partner in orthopedic and dental reconstruction, has submitted applications in both the United States and Europe seeking marketing approval for the OP-1 bone graft device, also known as the OP-1 Implant. (Source: Medical Design Online News)
Source: Medical Design Online News - January 1, 1996 Category: Medical Equipment Source Type: news